Halting the Epidemic of Addiction and Loss Act of 2025
- Last Action
- 7/17/2025
Actions
- 2025-07-17Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2025-07-17Introduced in Senate
CRS Summary
As of 2025-07-17 (00)
Halting the Epidemic of Addiction and Loss Act of 2025
This bill requires that, when the Department of Health and Human Services (HHS) issues new regulations or guidance on grant programs addressing opioid use disorders, references to an opioid overdose reversal drug (e.g., naloxone) must broadly include any opioid overdose reversal drug approved by the Food and Drug Administration.
Within one year after the bill’s enactment, HHS must update all references accordingly in regulations or guidance issued prior to the bill’s enactment that are applicable to State Opioid Response Grants, Tribal Opioid Response Grants, or certain other grants relating to substance use disorder prevention.
Cosponsors (1)
- Maggie Hassan (D-NH)
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.